
### [NCIT:C4573](http://purl.obolibrary.org/obo/NCIT_C4573)
**Label:** Malignant Skin Appendage Neoplasm

**Subclasses:** [NCIT:C4810](http://purl.obolibrary.org/obo/NCIT_C4810) (Malignant Sweat Gland Neoplasm), [NCIT:C27255](http://purl.obolibrary.org/obo/NCIT_C27255) (Eccrine Carcinoma), [NCIT:C27533](http://purl.obolibrary.org/obo/NCIT_C27533) (Primary Cutaneous Mucinous Carcinoma), [NCIT:C4114](http://purl.obolibrary.org/obo/NCIT_C4114) (Pilomatrical Carcinoma), [NCIT:C134831](http://purl.obolibrary.org/obo/NCIT_C134831) (Eyelid Sebaceous Gland Carcinoma), [NCIT:C27254](http://purl.obolibrary.org/obo/NCIT_C27254) (Papillary Eccrine Carcinoma), [NCIT:C43340](http://purl.obolibrary.org/obo/NCIT_C43340) (Ocular Sebaceous Carcinoma), [NCIT:C40308](http://purl.obolibrary.org/obo/NCIT_C40308) (Vulvar Apocrine Adenocarcinoma), [NCIT:C4472](http://purl.obolibrary.org/obo/NCIT_C4472) (Mucoepidermoid Skin Carcinoma), [NCIT:C43341](http://purl.obolibrary.org/obo/NCIT_C43341) (Extraocular Cutaneous Sebaceous Carcinoma), [NCIT:C40309](http://purl.obolibrary.org/obo/NCIT_C40309) (Vulvar Sebaceous Carcinoma), [NCIT:C43321](http://purl.obolibrary.org/obo/NCIT_C43321) (Malignant Germinative Follicular Epithelium Neoplasm), [NCIT:C40306](http://purl.obolibrary.org/obo/NCIT_C40306) (Vulvar Eccrine Porocarcinoma), [NCIT:C40307](http://purl.obolibrary.org/obo/NCIT_C40307) (Vulvar Clear Cell Hidradenocarcinoma), [NCIT:C43344](http://purl.obolibrary.org/obo/NCIT_C43344) (Carcinoma ex Eccrine Spiradenoma), [NCIT:C43345](http://purl.obolibrary.org/obo/NCIT_C43345) (Ductal Eccrine Adenocarcinoma), [NCIT:C40304](http://purl.obolibrary.org/obo/NCIT_C40304) (Malignant Vulvar Sweat Gland Neoplasm), [NCIT:C3682](http://purl.obolibrary.org/obo/NCIT_C3682) (Sweat Gland Tubular Carcinoma), [NCIT:C40305](http://purl.obolibrary.org/obo/NCIT_C40305) (Vulvar Eccrine Adenocarcinoma), [NCIT:C43346](http://purl.obolibrary.org/obo/NCIT_C43346) (Ductal Eccrine Carcinoma with Spindle Cell Elements), [NCIT:C5140](http://purl.obolibrary.org/obo/NCIT_C5140) (Apocrine Breast Carcinoma In Situ), [NCIT:C7581](http://purl.obolibrary.org/obo/NCIT_C7581) (Microcystic Adnexal Carcinoma), [NCIT:C5141](http://purl.obolibrary.org/obo/NCIT_C5141) (Apocrine Breast Carcinoma), [NCIT:C43347](http://purl.obolibrary.org/obo/NCIT_C43347) (Ductal Eccrine Carcinoma with Squamous Metaplasia), [NCIT:C4471](http://purl.obolibrary.org/obo/NCIT_C4471) (Adenoid Cystic Skin Carcinoma), [NCIT:C40369](http://purl.obolibrary.org/obo/NCIT_C40369) (Sebaceous Breast Carcinoma), [NCIT:C43326](http://purl.obolibrary.org/obo/NCIT_C43326) (Trichilemmocarcinoma), [NCIT:C5560](http://purl.obolibrary.org/obo/NCIT_C5560) (Eccrine Porocarcinoma), [NCIT:C43327](http://purl.obolibrary.org/obo/NCIT_C43327) (Malignant Proliferating Pilar Tumor), [NCIT:C6938](http://purl.obolibrary.org/obo/NCIT_C6938) (Sweat Gland Carcinoma), [NCIT:C128164](http://purl.obolibrary.org/obo/NCIT_C128164) (Vulvar Adenocarcinoma of Sweat Gland Type), [NCIT:C8409](http://purl.obolibrary.org/obo/NCIT_C8409) (Malignant Sebaceous Neoplasm), [NCIT:C5559](http://purl.obolibrary.org/obo/NCIT_C5559) (Malignant Eccrine Neoplasm), [NCIT:C54664](http://purl.obolibrary.org/obo/NCIT_C54664) (Hidradenocarcinoma), [NCIT:C4169](http://purl.obolibrary.org/obo/NCIT_C4169) (Apocrine Carcinoma), [NCIT:C4027](http://purl.obolibrary.org/obo/NCIT_C4027) (Paget Disease of the Vulva), [NCIT:C5457](http://purl.obolibrary.org/obo/NCIT_C5457) (Invasive Apocrine Breast Carcinoma), [NCIT:C6800](http://purl.obolibrary.org/obo/NCIT_C6800) (Malignant Apocrine Neoplasm), [NCIT:C5117](http://purl.obolibrary.org/obo/NCIT_C5117) (Spiradenocarcinoma), [NCIT:C3775](http://purl.obolibrary.org/obo/NCIT_C3775) (Adnexal Carcinoma), [NCIT:C43310](http://purl.obolibrary.org/obo/NCIT_C43310) (Malignant Hair Follicle Neoplasm), [NCIT:C43316](http://purl.obolibrary.org/obo/NCIT_C43316) (Malignant Outer Hair Sheath and Infundibulum Neoplasm), [NCIT:C5180](http://purl.obolibrary.org/obo/NCIT_C5180) (Malignant Breast Eccrine Spiradenoma), [NCIT:C40310](http://purl.obolibrary.org/obo/NCIT_C40310) (Sebaceous Carcinoma), 

**Class expressions from DL-Learner:**

- [UBERON:0002330](http://purl.obolibrary.org/obo/UBERON_0002330) (exocrine system) 60.00%
- [UBERON:0002097](http://purl.obolibrary.org/obo/UBERON_0002097) (skin of body) 60.00%
- [NCIT:C36156](http://purl.obolibrary.org/obo/NCIT_C36156) (Favorable Clinical Outcome) 60.00%
- Thing 51.79%
- [NCIT:C62285](http://purl.obolibrary.org/obo/NCIT_C62285) (Adnexal Differentiation) 28.90%
- [NCIT:C42585](http://purl.obolibrary.org/obo/NCIT_C42585) (Epithelial Differentiation) 23.87%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 22.53%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 22.15%
- [BFO:0000004](http://purl.obolibrary.org/obo/BFO_0000004) (null) 22.01%
- [BFO:0000002](http://purl.obolibrary.org/obo/BFO_0000002) (null) 22.01%
- [NCIT:C42095](http://purl.obolibrary.org/obo/NCIT_C42095) (Tissue Differentiation) 19.13%
- [NCIT:C35461](http://purl.obolibrary.org/obo/NCIT_C35461) (Clinical Course of Disease) 18.70%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) 13.24%
- [NCIT:C35867](http://purl.obolibrary.org/obo/NCIT_C35867) (Morphologic Finding) 12.58%
- [NCIT:C12922](http://purl.obolibrary.org/obo/NCIT_C12922) (Neoplastic Cell) 12.48%


